Canbi Pharma Tech Limited
236395-14-5 Eslicarbazepine Acetate
236395-14-5 Eslicarbazepine Acetate

236395-14-5 Eslicarbazepine Acetate

CAS:236395-14-5
MF:C17H16N2O3
MW:296.32
EINECS:636-617-2
MDL No.:MFCD06798333

Send Inquiry
Description

Properties

Appearance white solid
Melting point:183-185°C
Boiling point:427.4±55.0 °C
Density 1.32
storage temp. Sealed in dry,2-8°C
solubility H2O: insoluble
pka13.97±0.40

 

Application:

Esilicacepin Acetate (trade name: Zebinix/Aptiom, Eslicarbazepine acetate, commonly known as Eslicarbazepine acetate, is a novel antiepileptic drug that primarily inhibits the repeated abnormal discharges of brain neurons by blocking the conduction of action potentials, thereby controlling epileptic seizures. Moreover, long-term administration has good tolerance and high safety.

 

Synonyms:

Eslicarbazepine acetate

236395-14-5

BIA 2-093

Eslicarbazepine (acetate)

5H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-

(S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate

(10S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate

(S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide

S-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide

Eslicarbazepine acetate   

(10S)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide

5H-DIBENZ(B,F)AZEPINE-5-CARBOXAMIDE, 10-(ACETYLOXY)-10,11-DIHYDRO-, (10S)-

5H-Dibenz9b,f)azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-ESL

(10S)-10-acetoxy-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide

(10S)-5-CARBAMOYL-10,11-DIHYDRO-5H-DIBENZO(B,F)AZEPIN-10-YL ACETATE

BIA 2093

Zebinix  

Aptiom 

Eslicarbazapine Acetate

 

 

Hot Tags: 236395-14-5 eslicarbazepine acetate, China 236395-14-5 eslicarbazepine acetate manufacturers, suppliers, 2 Cyanophenylboronic acid, S 1 Boc 3 hydroxypiperidine, tert Butyl trans 4 2 oxoethyl cyclohexyl carbamate, 3-Dimethylaminopropylamine, 2 Chloro 2 deoxyadenosine, L 5 Methyltetrahydrofolate calcium

Inquiry
goTop

(0/10)

clearall